Metabolic Syndrome as a Risk Factor for Atrial Fibrillation in Patients with Acute Myocardial Infarction

Results: Seventy-five patients (51.4%) were obese (BMI ≥ 25) and 64 (44%) had MS. AF occurred in 33 (22.6%) patients. Age, MS, and visceral obesity were significantly associated with AF (p = 0.001, p = 0.003, and p = 0.03, respectively). There was no difference between obese and non-obese patients in the incidence of AF and VT. Multivariate analysis revealed that age and MS were independent risk factors of post-AMI AF. Conclusions: MS is an important and modifiable risk factor for new-onset AF especially in patients with AMI who underwent PCI.

[1]  D. Roden,et al.  Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study , 2008, Circulation.

[2]  L. Fauchier,et al.  Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. , 2008, Journal of the American College of Cardiology.

[3]  V. Somers,et al.  Atrial fibrillation and obesity--results of a meta-analysis. , 2008, American heart journal.

[4]  C. Rihal,et al.  Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. , 2006, The American journal of cardiology.

[5]  B. Gersh,et al.  Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. , 2006, American heart journal.

[6]  R. Habib,et al.  Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery , 2005, Circulation.

[7]  M. Bourassa.  Angiotensin II inhibition and prevention of atrial fibrillation and stroke. , 2005, Journal of the American College of Cardiology.

[8]  Kipshidze Nn,et al.  Effect of the metabolic syndrome on the electrophysiological parameters of the heart , 2005 .

[9]  K. Harjai,et al.  Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. , 2004, Journal of the American College of Cardiology.

[10]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[11]  Y. Ohnishi,et al.  Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. , 2003, The American journal of cardiology.

[12]  J. Goudevenos,et al.  Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[13]  Douglas W Mahoney,et al.  Left atrial volume as an index of left atrial size: a population-based study. , 2003, Journal of the American College of Cardiology.

[14]  A. Maggioni,et al.  Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data , 2001, Heart.

[15]  A. Leaf.  Plasma nonesterified fatty acid concentration as a risk factor for sudden cardiac death: the Paris Prospective Study. , 2001, Circulation.

[16]  K. Lee,et al.  Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. , 2001, The American journal of cardiology.

[17]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[18]  K A Schulman,et al.  Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. , 2000, Circulation.

[19]  S. Hohnloser,et al.  Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. , 1999, Journal of the American College of Cardiology.

[20]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[21]  V. Salomaa,et al.  Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke. , 1997, Stroke.

[22]  M. Lewis,et al.  Evidence for decidua-trophoblast interactions in early human pregnancy. , 1993, Human Reproduction.

[23]  C. Mewis,et al.  Use of β-Blockers in Atrial Fibrillation , 2002 .

[24]  H. Naito,et al.  Obesity is associated with increased myocardial oxidative stress , 1999, International Journal of Obesity.

[25]  R. Page,et al.  Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. , 1994, Circulation.

[26]  Y. Matsuzawa,et al.  Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.